The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Immune status of patients with ovarian cancer of III-IV stages after using of interferon-gamma (ingaron) in complex treatment.
Anna Yurevna Ardzha
No relevant relationships to disclose
Galina Andreevna Nerodo
No relevant relationships to disclose
Elena Yurievna Zlatnik
No relevant relationships to disclose
Andrey Vladimirovich Bakhtin
No relevant relationships to disclose
Elina T Mkrtchyan
No relevant relationships to disclose
Anna Petrovna Menshenina
No relevant relationships to disclose